Merck's COVID-19 pill narrowly wins FDA panel's support

miscellaneous

miscellaneous / miscellaneous 203 Views comments

In a closely watched review, an FDA panel voted 13 to 10 to recommend authorization of Merck's COVID-19 pill, though with many caveats.

Comments